Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Income from Continuing Operations (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Income from Continuing Operations for 16 consecutive years, with 1814000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Income from Continuing Operations fell 209.01% year-over-year to 1814000.0, compared with a TTM value of 5720000.0 through Sep 2025, down 312.1%, and an annual FY2024 reading of 554000.0, up 93.68% over the prior year.
  • Income from Continuing Operations was 1814000.0 for Q3 2025 at Rockwell Medical, down from 1556000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 1664000.0 in Q3 2024 and bottomed at 8942000.0 in Q4 2021.
  • Average Income from Continuing Operations over 5 years is 3453263.16, with a median of 2092000.0 recorded in 2023.
  • The sharpest move saw Income from Continuing Operations skyrocketed 179.54% in 2024, then plummeted 632.88% in 2025.
  • Year by year, Income from Continuing Operations stood at 8942000.0 in 2021, then soared by 73.61% to 2360000.0 in 2022, then soared by 31.65% to 1613000.0 in 2023, then surged by 51.7% to 779000.0 in 2024, then crashed by 132.86% to 1814000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for RMTI at 1814000.0 in Q3 2025, 1556000.0 in Q2 2025, and 1571000.0 in Q1 2025.